MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System, announced today a patient from the University of Rochester Medical ...
HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platforms, today announced the ...
MINNEAPOLIS, May 11, 2026--(BUSINESS WIRE)--HistoSonics, the developer of the Edison® Histotripsy System and novel histotripsy therapy platform, today announced it has submitted a De Novo request to ...
MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, (www.histosonics.com), the manufacturer of the non-invasive Edison® Histotripsy System and novel sonic beam therapy, announced today that the Centers of ...
After FDA approval in late 2023, the non-invasive liver tumor treatment histotripsy has been used at University of Michigan Health since early 2024. As the use of histotripsy expands across the state ...
With a generous donation from the Li Ka Shing Foundation, the LKS Faculty of Medicine at the University of Hong Kong (HKUMed) will be the first institution in Asia to introduce the groundbreaking ...
NEWPORT BEACH, Calif., Oct. 14, 2024 /PRNewswire/ -- Hoag announced today a new technology using ultrasound energy to precisely destroy liver tumors in a single outpatient visit. HistoSonics Edison ...
The future of non-invasive cancer therapy is bright. Liver tumors can now be destroyed—without radiation, chemotherapy or surgery—thanks to new medical technology known as histotripsy. Dr. Zendejas ...
NEW ORLEANS – Ochsner MD Anderson Cancer Center at The Gayle and Tom Benson Cancer Center in New Orleans is now offering histotripsy treatment, a revolutionary advancement for treating liver tumors, ...